Search Results 1821-1830 of 205048 for Treatment

  1. Migraine Clinical Trials - Mayo Clinic Research

    * Treatment duration: 4 treatments, each about 12 weeks apart; and * Visit frequency: about every 4 weeks, 14 visits in total. The first and last visit and ...

  2. Study finds stem cell therapy is safe and may benefit people with spinal cord injuries - Mayo Clinic

    ... Treatment of Paralysis Due to Traumatic Spinal Cord Injury, known as CELLTOP, were published in Nature Communications. Treatment process.

  3. Study Of Comparative Treatments For Retinal Vein Occlusion 2 (SCORE2) - Mayo Clinic

    intravitreal aflibercept (2.0 mg) every 4 weeks. SCORE2 aims to determine if bevacizumab is non-inferior to aflibercept for the treatment of macular edema ...

  4. Treatment Of Antibody-Mediated Rejection (ABMR) With CarBel - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer - Mayo Clinic

    ... treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials ...

  6. ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D - Mayo Clinic

    Secondary objectives include treatment comparisons with respect to overall survival, time to recurrence, time to distant recurrence, safety and tolerability, ...

  7. An Efficacy and Safety Study of Palovarotene for the Treatment of MO - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  8. Rollover Study Of Cenicriviroc For The Treatment Of Liver Fibrosis In Participants With Nonalcoholic Steatohepatitis - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  9. A Comparative Effectiveness Study Of Major Glycemia-lowering Medications For Treatment Of Type 2 Diabetes - Mayo Clinic

    ... treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials ...

  10. Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence - Mayo Clinic

    About this study. To prospectively collect blood and tumor tissue from esophageal cancer patients to identify specific esophageal cancer mutations that can ...